January 27, 2023
Seeking Alpha
Radisens Diagnostics: Radisens Diagnostics Limited Medical Equipment Deals and Alliances Profile Prices from USD $250
SummaryRadisens Diagnostics Ltd Radisens is a medical device company that offers diagnostic products. The company provides integrated nearpatient device for chronic disease diagnosis and monitoring. It offers technology product Gemini platform that include...
Read full article »
January 28, 2023
Pharmabiz
US FDA approves Abbott's Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy
Abbott announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal c... See more »
January 27, 2023
Moneycontrol
Cipla Q3 profit up 10%, brokerages remain positive
Macquarie has kept 'Outperform' rating on Cipla with a target at Rs 1,235 per share... See more »
January 27, 2023MarketScreener
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines... See more »
January 27, 20239to5Google
Fitbit removes screenshots showing redesigned Android app
Last fall, it looked like Fitbit was going to revamp its mobile apps. That has yet to launch, and Fit... See more »
January 27, 2023Garmin Blog
6 Everyday Reasons to Have an Active inReach Device
Though best known for use during outdoor activities in remote locations or extreme conditions, there ... See more »
January 28, 2023GizChina
Apple will Increase App Store Prices in the UK and Other Countries on February 13
Apple has said today that it will adjust the App Store Prices in certain countries due to a number of... See more »
January 27, 2023Medthority
TRANSCEND CLL 004 trial of Breyanzi met primary endpoint of complete response rate in patients with relapsed or refractory chronic lymphocytic leukemia.
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, sin... See more »
January 28, 2023Nasdaq
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-... See more »
January 28, 2023
Pharmabiz
US FDA approves Abbott's Proclaim XR spinal cord stimulation system to treat painful diabetic peripheral neuropathy
Abbott announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal c... See more »
January 27, 2023
Moneycontrol
Cipla Q3 profit up 10%, brokerages remain positive
Macquarie has kept 'Outperform' rating on Cipla with a target at Rs 1,235 per share... See more »
January 27, 2023MarketScreener
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl
(marketscreener.com) By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines... See more »
January 27, 20239to5Google
Fitbit removes screenshots showing redesigned Android app
Last fall, it looked like Fitbit was going to revamp its mobile apps. That has yet to launch, and Fit... See more »
January 27, 2023Garmin Blog
6 Everyday Reasons to Have an Active inReach Device
Though best known for use during outdoor activities in remote locations or extreme conditions, there ... See more »
January 28, 2023GizChina
Apple will Increase App Store Prices in the UK and Other Countries on February 13
Apple has said today that it will adjust the App Store Prices in certain countries due to a number of... See more »
January 27, 2023Medthority
TRANSCEND CLL 004 trial of Breyanzi met primary endpoint of complete response rate in patients with relapsed or refractory chronic lymphocytic leukemia.
Bristol Myers Squibb announced topline results from ITRANSCEND CLL 004, a Phase I/II, open-label, sin... See more »
January 28, 2023Nasdaq
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
It's that time of year when Wall Street analysts start adjusting their predictions, and one dividend-... See more »
